Search Results for "Psychosis In The Context Of Sodium Oxybate"
Original Source: Psychosis in the context of sodium oxybate therapy.
Sodium oxybate (brand name Xyrem) is a sodium salt of gamma-hydroxybutyric acid (GHB), an endogenous CNS depressant, which is an effective treatment of narcolepsy. As a drug of abuse, GHB produces severe psychiatric side effects and withdrawal. However, there are no reports of these effects when using clinically recommended doses. This paper presents a case of a patient who developed altered mental status while taking the recommended dose of sodium oxybate and subsequently became psychotic upon abrupt disco...
Matching Channels
Radioactive sodium iodine 131I radioiodine
Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...
KYNAMRO (mipomersen sodium) injection is an oligonucleotide inhibitor of apolipoprotein B-100 synthesis indicated as an adjunct to lipid-lowering medications and diet to reduce low density lipoprote...
Matching News
Audience: Neurology, Internal Medicine, Patient [Posted 12/17/2012] ISSUE: FDA reminded healthcare professionals and patients that the combined use of Xyrem (sodium oxybate) with alcohol or ce...
FDA Warns Against Alcohol, CNS Drug Use With Sodium Oxybate
Alcohol and central nervous system depressants, such as opioids, are added to contraindications in the label of sodium oxybate (Xyrem), which already prohibits use of insomnia drugs. News Alerts
FDA Issues Warning Against Using Xyrem (Sodium Oxybate) With Alcohol, Other Drugs
Tonix Pharmaceuticals: Revolutionizing Fibromyalgia Treatment
By Capital Traders Group:I recently wrote an article regarding Jazz Pharmaceutical (JAZZ) and its wonder drug, Xyrem. In short, Jazz dominates the market for narcolepsy treatment because Xyrem (sodium...
Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem®
DUBLIN, Sept. 11, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc. (Nasdaq: JAZZ) today announced that a new patent related to Xyrem® (sodium oxybate) oral solution titled "Microbiologically...
Concert, Jazz partner for sodium oxybate compounds
Concert Pharmaceuticals Inc. (Lexington, Mass.) granted Jazz Pharmaceuticals plc (NASDAQ:JAZZ) exclusive, worldwide rights to develop and commercialize Concert's deuterium-modified sodium oxybate comp...
Matching PubMed Articles
Psychosis in the context of sodium oxybate therapy.
Sodium oxybate (brand name Xyrem) is a sodium salt of gamma-hydroxybutyric acid (GHB), an endogenous CNS depressant, which is an effective treatment of narcolepsy. As a drug of abuse, GHB produces sev...
Sodium oxybate and sleep apnea: a clinical case.
Sodium oxybate (GHB, Xyrem, Jazz Pharmaceuticals) is used to treat cataplexy in patients with narcolepsy. We report the case of a middle aged, normo-ponderal narcoleptic woman without risk factors who...
BACKGROUND: Gamma-hydroxybutyric acid (GHB), well known as a party drug, especially in Europe, is also legally used (sodium oxybate, Xyrem®) to treat a rare sleep disorder, narcolepsy with cataplexy....
Narcolepsy with cataplexy is a sleep disorder characterized by excessive daytime sleepiness, irresistible sleep episodes, and sudden loss of muscle tone (cataplexy) mostly triggered by emotions. Narco...
